DENTSPLY Sirona Inc [XRAY] stock prices are up 0.44% to $11.34 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The XRAY shares have gain 14.66% over the last week, with a monthly amount drifted -11.82%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DENTSPLY Sirona Inc [NASDAQ: XRAY] stock has seen the most recent analyst activity on November 07, 2025, when William Blair downgraded its rating to a Mkt Perform. Previously, Morgan Stanley downgraded its rating to Equal-Weight on April 15, 2025, and kept the price target unchanged to $14. On March 13, 2025, downgrade downgraded it’s rating to Hold. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $20 on February 14, 2025. Jefferies downgraded its rating to a Hold and reduced its price target to $20 on January 23, 2025. Evercore ISI downgraded its rating to In-line for this stock on January 07, 2025, but kept the price target unchanged to $20. In a note dated December 04, 2024, Mizuho initiated a Neutral rating and provided a target price of $21 on this stock.
The stock price of DENTSPLY Sirona Inc [XRAY] has been fluctuating between $9.85 and $20.59 over the past year. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. DENTSPLY Sirona Inc [NASDAQ: XRAY] shares were valued at $11.34 at the most recent close of the market. An investor can expect a potential return of 41.09% based on the average XRAY price forecast.
Analyzing the XRAY fundamentals
The DENTSPLY Sirona Inc [NASDAQ:XRAY] reported sales of 3.62B for trailing twelve months, representing a drop of -4.94%. Gross Profit Margin for this corporation currently stands at 0.51% with Operating Profit Margin at -0.14%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.24%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.48 and Total Capital is -0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.23 points at the first support level, and at 11.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.44, and for the 2nd resistance point, it is at 11.54.
Ratios To Look Out For
It’s worth pointing out that DENTSPLY Sirona Inc [NASDAQ:XRAY]’s Current Ratio is 1.47. As well, the Quick Ratio is 0.99, while the Cash Ratio is 0.26. Considering the valuation of this stock, the price to sales ratio is 0.62, the price to book ratio is 1.53.
Transactions by insiders
Recent insider trading involved VARON LESLIE F, Director, that happened on Nov 24 ’25 when 9337.0 shares were purchased. Director, LUCIER GREGORY T completed a deal on Mar 03 ’25 to buy 15142.0 shares. Meanwhile, Former Officer Coleman Glenn bought 15759.0 shares on Jan 27 ’25.
